The Next Level of Renal Care
By Rice Powell, Chief Executive Officer and Chairman of the Management Board of Fresenius Medical Care
It's an inconvenient truth, but we're facing a public health crisis that has absolutely nothing to do with a virus. Instead, it's mostly about demographic change: The global population is growing, and so is the number of old and chronically ill people. By 2030, around 1 billion men and women will be 65 or older, more than half a billion will live with diabetes, and over 2 billion will suffer from hypertension.1
Our aging generation of patients deserves health care of exceptional quality – and will require it on an unprecedented scale. But in many countries, health care expenditure has grown faster than Gross Domestic Product (GDP) for decades, pushing systems to the limits of their capacity. The new wave of older patients with multiple chronic diseases threatens to overwhelm them.2
So, let’s be realistic, we need to do the impossible: improve care and reduce costs. The good news is there's a solution for this: Value-based care. We at Fresenius Medical Care have tried and tested it for well over a decade.
1 Cf. 20200921_CMD 2020 Rice Powell_TP final, p.11. Der besseren Lesbarkeit wegen wurden 578 M Diabeteskranke auf „over half a billion“ gerundet. Die UN rechnet für 2030 mit einer Weltbevölkerung von 8.5 Mrd. Menschen. Hat jeder 4. Bluthochdruck, sind das 2,125 Mrd. Menschen, d.h. „over 2 billion“ (https://www.un.org/sustainabledevelopment/blog/2015/07/un-projects-world-population-to-reach-8-5-billion-by-2030-driven-by-growth-in-developing-countries/).
2 Cf. 20200921_CMD 2020 Rice Powell_TP final, p.6
3 Cf. 20200921_CMD 2020 Rice Powell_TP final, p.11
4 Annual Medical Report: FMC_AMR_2020_Clinical Performance Supports Organized Value-Based Care, p. 91